Katrien De Wolf

Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F‐FDG‐PET) in the treatment of bone metastases: results from a 3‐arm randomized phase II trial

W. De Neve, I. Goethals, P. Ost, 2017, Journal of medical imaging and radiation oncology.

Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial.

Els Goetghebeur, Ingeborg Goethals, Lennart Jans, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

E. Goetghebeur, N. Lumen, K. Decaestecker, 2017, Radiation Oncology.

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy

B. Lambrecht, G. De Meerleer, P. Ost, 2015, Oncoimmunology.

Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma.

E. Goetghebeur, L. Brochez, N. Sundahl, 2017, International journal of radiation oncology, biology, physics.

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

E. Goetghebeur, K. Decaestecker, V. Fonteyne, 2017, Journal of Translational Medicine.

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

E. Goetghebeur, N. Lumen, K. Decaestecker, 2017, Radiation oncology.

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

L. Brochez, N. Sundahl, P. Ost, 2017, Journal of Translational Medicine.